Save cost and increase trial enrollment rate through at-home, non-invasive DNA testing

Sano supports precision medicine researchers in planning and executing their DNA testing strategy with confidence and accuracy.

Save cost and increase trial enrolment rate through at-home, non-invasive DNA testing

Sano supports precision medicine researchers in planning and executing their DNA testing strategy with confidence and accuracy.

Group 48096092 (1)
az-logo
lilly-logo
recode-logo
5-1
6-1

Working with exceptional life science companies and patient organisations

Working with exceptional life science companies and patient organisations

desktop-logos
logos web
High Conversion landing icon
Select DNA testing to fit your study’s needs
Sano provides a comprehensive range of DNA testing services, including:
secuencing
If needed, Sano can also integrate with your clinical sites or labs to manage biomarker testing.
Select DNA testing to fit your study’s needs
Group 48096016
Better for patients
✅  At-home DNA testing kits that can be self-administered in less than 10 minutes.
✅  Saliva test provides a non-invasive alternative to blood draws.
✅  No need for time-consuming lab visits
Group 48096081-3
Better for sites
✅  No need to test any patients on-site
✅  Patients coming for pre-screening have already been genetically verified
Group 48096078-1
Better for sponsors
✅  Costs are reduced up to 80% by choosing saliva testing versus in-clinic blood testing
✅  At-home saliva samples produce the equivalent genetic data
✅  Saliva tests allow for longer storage
Move more quickly with a seamless and fully-managed process
We know that sites and sponsors have limited time and resources to manage DNA testing. That’s why Sano handles:
Frame 48096059
Kit ordering in a variety of languages
Frame 48096042
Sample collection from participants’ doorsteps
Frame 48096042 (1)
Sample processing and data generation and storage
Frame 48096059 (1)
Analytics and bioinformatics
Frame 48096042 (4)
Returning results
Frame 48096042 (3)-1
Genetic counseling
parkinsons-case-study

Doubling the industry benchmark for
Genetic Parkinson’s Patient Recruitment

An innovative biotech company approached Sano to identify and screen Parkinson's Disease patients with LRRK2:G2019S mutation in the USA and Europe. Through its extensive partner network, direct-to-patient recruitment channels, and at-home DNA testing, Sano identified eligible patients at a rate 2x the industry benchmark. This led to an expansion to other regions and a 55% cost reduction compared to DNA testing through site visits.

All appropriate details are accessible to patients, healthcare providers, sponsors, and sites through the Sano Platform.

Reliable DNA testing
that can grow with your study

Certification section

GxPWe prioritise quality and accuracy by collaborating exclusively with GxP/CLIA-CAP certified lab partners, ensuring trusted results.

This precision testing extends internationally. Our global capabilities include:

  • Kits in native language
  • Multi-language platform
  • Logistics covered
  • Lab partners established
  • Regulatory considerations handled
map
Group 48095851

Case study: 2x the industry benchmark for Genetic Parkinson’s Patient Recruitment

An innovative biotech company approached Sano to identify and screen Parkinson's Disease patients with LRRK2:G2019S mutation in the USA and Canada. Through thoughtful recruitment in combination with at-home DNA testing, Sano identified eligible patients at a rate 2x the industry benchmark. We screened patients with consent, tested those most suitable, provided genetic counseling as needed, and returned results to patients and HCPs.

This success led to an expansion to other regions and a 55% cost reduction compared to DNA testing through site visits.

divider-1
x2
Greater success rate of LRRK2:G2019S patients recruited than industry benchmark.
~55%
Cost saved using at-home DNA testing service vs site visit.
map x
Program expansion into new geographies.

Get in touch

We’ll respond to you within one working day